Another WNY technology company joins the fight against Coronavirus/Covid-19. First Wave Technologies’ IsoVENT™ product allows one ventilator to serve multiple patients, a tremendous advantage in the age of Coronavirus/Covid-19. First Wave just inked a deal with a subsidiary of Cannon USA to manufacture the IsoVENT™ (pending FDA approval) and Vauxhall International to facilitate entry to the African market for all the company’s medical devices. Congratulations to Brian Bell, CEO, and the whole First Wave team! NOTE: the WNY Business Development Fund in which Insyte Consulting is a partner was an early investor in First Wave Technologies. Full press release here.